ConductScience.org, home

Paper38487526

The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer.

Dou T and 7 others. Front Immunol, 2024. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer. Papers, record 38487526. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38487526

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
2.93, provisional
iCite
Revised in PubMed
2024-04-16
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dou TTingyao
2Li JJing
3Zhang YYaochen
4Pei WWanru
5Zhang BBinyue
6Wang BBin
7Wang YYanhong
8Jia HHongyan

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Female
Humans
Tumor Microenvironment
Endothelial Cells
Adipocytes
Fibroblasts

Source PubMed

Download CSV of topics

References197

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127162480Immunotherapy with methyl gallate, an inhibitor of Treg cell migration, enhances the anti-cancer effect of cisplatin therapy.Korean J Physiol Pharmacol2016https://conductscience.org/library/papers/27162480PubMed
234579743Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34579743PubMed
319305395Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus.Nat Immunol2009https://conductscience.org/library/papers/19305395PubMed
430042442Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling.Cell Death Dis2018https://conductscience.org/library/papers/30042442PubMed
528574616The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.J Cell Biochem2018https://conductscience.org/library/papers/28574616PubMed
622516258Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.Cancer Cell2012https://conductscience.org/library/papers/22516258PubMed
730294328Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells.Front Immunol2018https://conductscience.org/library/papers/30294328PubMed
830134951IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/30134951PubMed
929774124Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1.Oncotarget2018https://conductscience.org/library/papers/29774124PubMed
1024002734Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells.Breast Cancer Res Treat2013https://conductscience.org/library/papers/24002734PubMed
1130034942Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.Am J Cancer Res2018https://conductscience.org/library/papers/30034942PubMed
1227875786Inflammation, dysregulated metabolism and aromatase in obesity and breast cancer.Curr Opin Pharmacol2016https://conductscience.org/library/papers/27875786PubMed
1331014367The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells.Breast Cancer Res2019https://conductscience.org/library/papers/31014367PubMed
1420521754Treatment of breast cancer.Am Fam Physician2010https://conductscience.org/library/papers/20521754PubMed
1522224776Immune regulatory function of B cells.Annu Rev Immunol2012https://conductscience.org/library/papers/22224776PubMed
1631096176The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.Ann Diagn Pathol2019https://conductscience.org/library/papers/31096176PubMed
1727671678Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes.Cancer Res2016https://conductscience.org/library/papers/27671678PubMed
1820702612A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.Clin Cancer Res2010https://conductscience.org/library/papers/20702612PubMed
1932849585The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.Front Immunol2020https://conductscience.org/library/papers/32849585PubMed
2034439387Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment.Cancers (Basel)2021https://conductscience.org/library/papers/34439387PubMed

See all 197 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42920907Molecular and immune-mediated resistance to antibody-drug conjugates in breast cancer.Front Immunol2026https://conductscience.org/library/papers/42920907PubMed
42357290Polymeric Nano Drug Delivery Systems for Overcoming Tumor Microenvironment-Mediated Drug Resistance.Pharmaceutics2026https://conductscience.org/library/papers/42357290PubMed
42347041A Multiresolution Breast Cancer CIBERSORTx Resource Validated for Accuracy, Interpretive Limits, and Biological and Clinical Coherence in Tumor Microenvironment Deconvolution.Methods Protoc2026https://conductscience.org/library/papers/42347041PubMed
42332744Decoding triple negative breast cancer bone metastasis: from 3D bioprinted models to clinical translation.J Nanobiotechnology2026https://conductscience.org/library/papers/42332744PubMed
42078644C-MPL signaling in breast cancer: molecular mechanisms and therapeutic implications.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/42078644PubMed
41699782Therapeutic Effect of Gemcitabine Combined With Angelica Polysaccharide on Triple Negative Breast Cancer in Mice.Integr Cancer Ther2026https://conductscience.org/library/papers/41699782PubMed
41681885Targeting the Tumor Microenvironment in Triple-Negative Breast Cancer: Emerging Roles of Monoclonal Antibodies and Immune Modulation.Cancers (Basel)2026https://conductscience.org/library/papers/41681885PubMed
41286375Impact of single-cell cell cycle regulation of intercellular communication on the prognosis of hepatocellular carcinoma in the tumor microenvironment.Clin Exp Med2025https://conductscience.org/library/papers/41286375PubMed
40982113KLF4 in cancer chemoresistance: molecular mechanisms and therapeutic implications.Discov Oncol2025https://conductscience.org/library/papers/40982113PubMed
40968428Therapeutic Potential of Underexplored Phytoconstituents Targeting Molecular Pathways in Breast Cancer Subtypes.Mini Rev Med Chem2025https://conductscience.org/library/papers/40968428PubMed
409649893D Bioprinting and Artificial Intelligence for Tumor Microenvironment Modeling: A Scoping Review of Models, Methods, and Integration Pathways.Mol Pharm2025https://conductscience.org/library/papers/40964989PubMed
40520231Reference-free deconvolution of complex samples based on cross-cell-type differential analysis: Systematic evaluations with various feature selection options.Front Genet2025https://conductscience.org/library/papers/40520231PubMed
40005948Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer.Vet Sci2025https://conductscience.org/library/papers/40005948PubMed
39944834Investigating the role of cathepsins in breast cancer progression: a Mendelian randomization study.Front Oncol2025https://conductscience.org/library/papers/39944834PubMed
39835122Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma.Front Immunol2024https://conductscience.org/library/papers/39835122PubMed
39806516Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.J Hematol Oncol2025https://conductscience.org/library/papers/39806516PubMed
39769466Advancements in the Application of scRNA-Seq in Breast Research: A Review.Int J Mol Sci2024https://conductscience.org/library/papers/39769466PubMed
39364737Polyphyllin II inhibits breast cancer cell proliferation via the PI3K/Akt signaling pathway.Mol Med Rep2024https://conductscience.org/library/papers/39364737PubMed
39154313Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis.Clin Transl Oncol2025https://conductscience.org/library/papers/39154313PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38487526

GET https://conductscience.org/api/papers/v1/38487526/references?page=2